A new experimental hair-loss treatment has sent Cosmo Pharmaceuticals’ stock soaring. But doctors say the drug is promising ...
An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III trials involving 1,500 men, participants using the topical solution ...
The possibility of a long-awaited change in the treatment of male baldness has been raised by Cosmo Pharmaceuticals’ ...
Cosmo Pharmaceuticals' new drug, clascoterone, shows encouraging phase 3 results in treating male baldness, potentially revolutionising hair loss treatments.
Italian pharmaceutical company Cosmo Pharmaceuticals announced that its recently developed new male-pattern hair loss drug has shown significant results in Phase 3 clinical trials. The existing ...